C. Dejean

768 total citations
56 papers, 453 citations indexed

About

C. Dejean is a scholar working on Surgery, Radiation and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. Dejean has authored 56 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 19 papers in Radiation and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. Dejean's work include Advanced Radiotherapy Techniques (19 papers), Medical Imaging Techniques and Applications (9 papers) and Management of metastatic bone disease (7 papers). C. Dejean is often cited by papers focused on Advanced Radiotherapy Techniques (19 papers), Medical Imaging Techniques and Applications (9 papers) and Management of metastatic bone disease (7 papers). C. Dejean collaborates with scholars based in France, Italy and United Kingdom. C. Dejean's co-authors include Denis Sarrouilhe, Marc Mesnil, Jean‐Michel Hannoun‐Lévi, G. Kantor, Marie-Eve Chand-Fouché, Jean‐Pierre Gérard, J. Doyen, Mathieu Gautier, Paul Sargos and A. Courdi and has published in prestigious journals such as European Journal of Cancer, Current Medicinal Chemistry and Radiotherapy and Oncology.

In The Last Decade

C. Dejean

49 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Dejean France 12 140 133 119 93 84 56 453
Peter Hass Germany 14 128 0.9× 153 1.2× 99 0.8× 97 1.0× 53 0.6× 53 583
Yu Murakami Japan 13 121 0.9× 111 0.8× 101 0.8× 90 1.0× 59 0.7× 53 630
Zhenyin Liu China 17 125 0.9× 151 1.1× 71 0.6× 28 0.3× 91 1.1× 35 617
Kenneth Ocran Germany 17 187 1.3× 168 1.3× 213 1.8× 72 0.8× 122 1.5× 36 860
Brandon Stone United States 11 115 0.8× 81 0.6× 44 0.4× 32 0.3× 156 1.9× 17 460
Dan Garwood United States 7 71 0.5× 360 2.7× 120 1.0× 70 0.8× 39 0.5× 16 650
H. J. Biersack Germany 9 87 0.6× 94 0.7× 58 0.5× 33 0.4× 44 0.5× 44 411
Justin Lee Canada 11 44 0.3× 65 0.5× 79 0.7× 57 0.6× 85 1.0× 29 405
Yoshiko Watanabe Japan 19 276 2.0× 370 2.8× 183 1.5× 47 0.5× 160 1.9× 60 1.1k
M. Di Paola Italy 13 134 1.0× 152 1.1× 218 1.8× 40 0.4× 44 0.5× 26 601

Countries citing papers authored by C. Dejean

Since Specialization
Citations

This map shows the geographic impact of C. Dejean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Dejean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Dejean more than expected).

Fields of papers citing papers by C. Dejean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Dejean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Dejean. The network helps show where C. Dejean may publish in the future.

Co-authorship network of co-authors of C. Dejean

This figure shows the co-authorship network connecting the top 25 collaborators of C. Dejean. A scholar is included among the top collaborators of C. Dejean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Dejean. C. Dejean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chauvie, Stéphane, Loredana G. Marcu, C. Dejean, et al.. (2024). The role of medical physics experts in clinical trials: A guideline from the European Federation of Organisations for Medical Physics. Physica Medica. 126. 104821–104821.
2.
Carsuzaa, Florent, Arnaud Beddok, Sophie Deneuve, et al.. (2024). Enjeux et mise en œuvre de radiothérapie postopératoire après chirurgie reconstructrice avec lambeau dans les cancers de la tête et du cou. Bulletin du Cancer. 111(5). 496–504. 1 indexed citations
3.
Osman, David, R. de Crevoisier, C. Dejean, et al.. (2023). Enjeux éthiques de l’information en oncologie radiothérapie : penser le risque et construire l’alliance thérapeutique. Cancer/Radiothérapie. 27(6-7). 480–486.
4.
Gérard, Jean‐Pierre, Arthur Sun Myint, N. Barbet, et al.. (2022). Targeted Radiotherapy Using Contact X-ray Brachytherapy 50 kV. Cancers. 14(5). 1313–1313. 6 indexed citations
5.
Chand-Fouché, Marie-Eve, Jocelyn Gal, D. Lam Cham Kee, et al.. (2022). Feasibility and early toxicity of intraoperative radiotherapy for breast cancer using the papillon + system: First results. Clinical and Translational Radiation Oncology. 38. 47–52. 1 indexed citations
6.
Huguet, F., R. de Crevoisier, C. Dejean, et al.. (2021). Enjeux éthiques de la pratique des soins à visée palliative en oncologie radiothérapique. Cancer/Radiothérapie. 25(6-7). 699–706. 2 indexed citations
7.
Volpe, Stefania, Pierre‐Yves Bondiau, L. Claude, et al.. (2021). Postsurgical geometrical variations of tumor bed and brainstem during photon and proton therapy for pediatric tumors of the posterior fossa: dosimetric impact and predictive factors. Strahlentherapie und Onkologie. 197(12). 1113–1123. 3 indexed citations
8.
Gérard, Jean‐Pierre, N. Barbet, C. Dejean, et al.. (2021). Contact X-ray brachytherapy for rectal cancer: Past, present, and future. Cancer/Radiothérapie. 25(8). 795–800. 7 indexed citations
9.
Dejean, C., Alexandre Escande, Patrick Le Tallec, et al.. (2020). Démocratie sanitaire : le patient partenaire de sa prise en charge. Cancer/Radiothérapie. 24(6-7). 736–743. 5 indexed citations
11.
Sarrouilhe, Denis & C. Dejean. (2016). Les relations entre le bisphénol A et les troubles du spectre autistique se précisent : la sérotonine est-elle le lien manquant ?. L Encéphale. 43(4). 402–404. 10 indexed citations
12.
Troussier, I., F. Huguet, S. Servagi-Vernat, et al.. (2015). Place de l’arcthérapie modulée et de la chimiothérapie concomitante dans la prise en charge des cancers du canal anal localement évolués. Cancer/Radiothérapie. 19(2). 127–138. 3 indexed citations
13.
Dejean, C. & Darren E. Richard. (2013). Mécanismes d’action des glucocorticoïdes. La Revue de Médecine Interne. 34(5). 264–268. 4 indexed citations
14.
Thariat, Juliette, Christine Kerr, G. Angellier, et al.. (2013). Métastases osseuses : les nouvelles techniques d’irradiation et traitements combinés ablatifs décalent-ils les standards ?. Bulletin du Cancer. 100(11). 1187–1197. 6 indexed citations
15.
Pierrat, N., et al.. (2013). Calcul de la distribution de dose en curiethérapie. Cancer/Radiothérapie. 17(2). 89–92. 6 indexed citations
16.
Giraud, P., Guy Kantor, Michael Yassa, et al.. (2011). Two-Year Clinical Experience With Tomotherapy: The French National Cancer Institute Project on Implementing New Technology. Cancer Investigation. 29(8). 557–563. 6 indexed citations
17.
Dejean, C., Paul Sargos, J. Caron, et al.. (2011). Expérience de l’institut Bergonié à propos de 14 cas de tomothérapie hélicoïdale de tumeurs axiales et para-axiales. Cancer/Radiothérapie. 15(5). 404–412. 3 indexed citations
18.
Dejean, C., Dimitri Lefkopoulos, F. Nataf, & Michel Schlienger. (2001). [Radiosurgery of cerebral arteriovenous malformations: methodology of the dose prescription and its implications for dosimetric results. Retrospective study of 408 cases].. PubMed. 47(2-3 Pt 2). 239–45. 5 indexed citations
19.
Dejean, C., Dimitri Lefkopoulos, J.N. Foulquier, M. Schlienger, & E. Touboul. (2001). Définition automatique de l’isodose de prescription pour les irradiations stéréotaxiques de malformations artérioveineuses. Cancer/Radiothérapie. 5(2). 138–149. 6 indexed citations
20.
Dejean, C.. (1951). [Restoration of the lacrimal canal with a funnel-shaped acrylic tube].. PubMed. 135(27-28). 468–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026